Back
Akebia Therapeutics Stock Price Chart
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Buy
59
AKBA
Akebia Therapeutics
Last Price:
1.81
Seasonality Move:
42.93%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- The current trend is moderately bullish and AKBA is experiencing slight selling pressure.
Akebia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.87 | Sell |
| 20-day SMA: | 1.8 | Sell |
| 50-day SMA: | 1.54 | Buy |
| 200-day SMA: | 1.41 | Buy |
| 8-day EMA: | 1.83 | Sell |
| 20-day EMA: | 1.77 | Buy |
| 50-day EMA: | 1.61 | Buy |
| 200-day EMA: | 1.4 | Buy |
Akebia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 55.22 | Buy |
| Chaikin Money Flow: | -573816 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.54 - 1.92) | Buy |
| Bollinger Bands (100): | (1.2 - 1.66) | Buy |
Akebia Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akebia Therapeutics Stock
Is Akebia Therapeutics Stock a Buy?
- Akebia Therapeutics share price is 1.79 while AKBA 8-day simple moving average is 1.87, which is a Sell signal.
- The stock price of AKBA is 1.79 while Akebia Therapeutics 20-day SMA is 1.80, which makes it a Sell.
- Akebia Therapeutics 50-day simple moving average is 1.54 while AKBA share price is 1.79, making it a Buy technically.
- AKBA stock price is 1.79 and Akebia Therapeutics 200-day simple moving average is 1.41, creating a Buy signal.
AKBA Technical Analysis vs Fundamental Analysis
Buy
59
Akebia Therapeutics (AKBA)
is a Buy
Is Akebia Therapeutics a Buy or a Sell?
-
Akebia Therapeutics stock is rated a Buy
The current Akebia Therapeutics [AKBA] share price is $1.79. The Score for AKBA is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Akebia Therapeutics Stock Info
Market Cap:
390.54M
Price in USD:
1.79
Share Volume:
1.15M
Akebia Therapeutics 52-Week Range
52-Week High:
2.48
52-Week Low:
0.80
Buy
59
Akebia Therapeutics (AKBA)
is a Buy
Akebia Therapeutics Share Price Forecast
-
What is the Akebia Therapeutics stock price today?
The Akebia Therapeutics stock price is 1.79 USD today. -
Will AKBA stock go up or go down?
Akebia Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Akebia Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akebia Therapeutics is not overvalued.
Is Akebia Therapeutics Stock a Buy?
- Akebia Therapeutics share price is 1.79 while AKBA 8-day exponential moving average is 1.83, which is a Sell signal.
- The stock price of AKBA is 1.79 while Akebia Therapeutics 20-day EMA is 1.77, which makes it a Buy.
- Akebia Therapeutics 50-day exponential moving average is 1.61 while AKBA share price is 1.79, making it a Buy technically.
- AKBA stock price is 1.79 and Akebia Therapeutics 200-day simple moving average is 1.40, creating a Buy signal.
Fundamental Analysis of Akebia Therapeutics
Is Akebia Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.07 per share.
Technical Analysis of Akebia Therapeutics
Should I short Akebia Therapeutics stock?
- AKBA Moving Average Covergence Divergence (MACD) indicator is 0.09, suggesting Akebia Therapeutics is a Buy
- Akebia Therapeutics Relative Strength Index (RSI) is 55.22, which suggest Akebia Therapeutics is overbought
- The Bollinger Bands (25) for Akebia Therapeutics is (1.54 - 1.92), which suggest Akebia Therapeutics is a Buy
- The Bollinger Bands (100) for Akebia Therapeutics is (1.2 - 1.66), which suggest Akebia Therapeutics is a Buy
* Akebia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.